These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34339076)

  • 41. Fraction From Lycium barbarum Polysaccharides Reduces Immunotoxicity and Enhances Antitumor Activity of Doxorubicin in Mice.
    Deng X; Luo S; Luo X; Hu M; Ma F; Wang Y; Zhou L; Huang R
    Integr Cancer Ther; 2018 Sep; 17(3):860-866. PubMed ID: 29355051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metformin augments doxorubicin cytotoxicity in mammary carcinoma through activation of adenosine monophosphate protein kinase pathway.
    El-Ashmawy NE; Khedr NF; El-Bahrawy HA; Abo Mansour HE
    Tumour Biol; 2017 May; 39(5):1010428317692235. PubMed ID: 28459206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo.
    Mookerjee A; Basu JM; Majumder S; Chatterjee S; Panda GS; Dutta P; Pal S; Mukherjee P; Efferth T; Roy S; Choudhuri SK
    BMC Cancer; 2006 Nov; 6():267. PubMed ID: 17107616
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel magnetic nanoparticle drug carrier for enhanced cancer chemotherapy.
    Chao X; Zhang Z; Guo L; Zhu J; Peng M; Vermorken AJ; Van de Ven WJ; Chen C; Cui Y
    PLoS One; 2012; 7(10):e40388. PubMed ID: 23056167
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vesicular gold assemblies based on host-guest inclusion and its controllable release of doxorubicin.
    Ha W; Kang Y; Peng SL; Ding LS; Zhang S; Li BJ
    Nanotechnology; 2013 Dec; 24(49):495103. PubMed ID: 24231410
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PEGylated-PLGA Nanoparticles Coated with pH-Responsive Tannic Acid-Fe(III) Complexes for Reduced Premature Doxorubicin Release and Enhanced Targeting in Breast Cancer.
    Hu F; Zhang R; Guo W; Yan T; He X; Hu F; Ren F; Ma X; Lei J; Zheng W
    Mol Pharm; 2021 Jun; 18(6):2161-2173. PubMed ID: 32515968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
    Elbialy NS; Fathy MM; Khalil WM
    Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reversal of resistance against doxorubicin by a newly developed compound, oxalyl bis(N-phenyl)hydroxamic acid in vitro.
    Choudhuri SK; Chatterjee A
    Anticancer Drugs; 1998 Oct; 9(9):825-32. PubMed ID: 9840730
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Poly(methacrylic acid)-Coated Gold Nanoparticles: Functional Platforms for Theranostic Applications.
    Yilmaz G; Demir B; Timur S; Becer CR
    Biomacromolecules; 2016 Sep; 17(9):2901-11. PubMed ID: 27447298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synergistic efficacy of γ-radiation together with gallium trichloride and/or doxorubicin against Ehrlich carcinoma in female mice.
    Kandil E; Aziz NA
    Tumour Biol; 2016 Feb; 37(2):1825-34. PubMed ID: 26318299
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Doxorubicin Conjugated to Glutathione Stabilized Gold Nanoparticles (Au-GSH-Dox) as an Effective Therapeutic Agent for Feline Injection-Site Sarcomas-Chick Embryo Chorioallantoic Membrane Study.
    Zabielska-Koczywąs K; Dolka I; Król M; Żbikowski A; Lewandowski W; Mieczkowski J; Wójcik M; Lechowski R
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28208720
    [TBL] [Abstract][Full Text] [Related]  

  • 52. K. ZHENG ET AL.Gold-nanoparticle-based multistage drug delivery system for antitumor therapy.
    Zheng K; Zhou D; Wu L; Li J; Zhao B; Zhang S; He R; Xiao L; Zoya I; Yu L; Zhang Y; Li Y; Gao J; Li K
    Drug Deliv; 2022 Dec; 29(1):3186-3196. PubMed ID: 36226475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effective nuclear delivery of doxorubicin from dextran-coated gold nanoparticles larger than nuclear pores.
    Jang H; Ryoo SR; Kostarelos K; Han SW; Min DH
    Biomaterials; 2013 Apr; 34(13):3503-10. PubMed ID: 23395274
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Investigation of the drug binding properties and cytotoxicity of DNA-capped nanoparticles designed as delivery vehicles for the anticancer agents doxorubicin and actinomycin D.
    Alexander CM; Dabrowiak JC; Maye MM
    Bioconjug Chem; 2012 Oct; 23(10):2061-70. PubMed ID: 23043330
    [TBL] [Abstract][Full Text] [Related]  

  • 55. C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment.
    Prylutska S; Grynyuk I; Matyshevska O; Prylutskyy Y; Evstigneev M; Scharff P; Ritter U
    Drugs R D; 2014 Dec; 14(4):333-40. PubMed ID: 25504158
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dual-Energy CT Imaging of Tumor Liposome Delivery After Gold Nanoparticle-Augmented Radiation Therapy.
    Ashton JR; Castle KD; Qi Y; Kirsch DG; West JL; Badea CT
    Theranostics; 2018; 8(7):1782-1797. PubMed ID: 29556356
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting Cancer Resistance via Multifunctional Gold Nanoparticles.
    Pedrosa P; Corvo ML; Ferreira-Silva M; Martins P; Carvalheiro MC; Costa PM; Martins C; Martins LMDRS; Baptista PV; Fernandes AR
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31694227
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A pH-sensitive nanotherapeutic system based on a marine sulfated polysaccharide for the treatment of metastatic breast cancer through combining chemotherapy and COX-2 inhibition.
    Zhang T; Liu H; Li Y; Li C; Wan G; Chen B; Li C; Wang Y
    Acta Biomater; 2019 Nov; 99():412-425. PubMed ID: 31494294
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety, pharmacokinetics and biodistribution studies of a beta-galactoside prodrug of doxorubicin for improvement of tumor selective chemotherapy.
    Devalapally H; Rajan KS; Akkinepally RR; Devarakonda RK
    Drug Dev Ind Pharm; 2008 Aug; 34(8):789-95. PubMed ID: 18608462
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.